Esther Revai-Lechtich (Esther Revai Lechtich)

Years Active: 2022-2023
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

Susana Moleirinho, Yohei Kitamura, Paulo S G N Borges, Sophia Auduong, Seyda Kilic, David Deng, Nobuhiko Kanaya, David Kozono, Jing Zhou, Jeffrey J Gray, Esther Revai-Lechtich, Yanni Zhu, Khalid Shah
Fate and Efficacy of Engineered Allogeneic Stem Cells Targeting Cell Death and Proliferation Pathways in Primary and Brain Metastatic Lung Cancer. Stem cells translational medicine (2023)
Deepak Bhere, Sung Hugh Choi, Pim van de Donk, David L Hope, Kiki Gortzak, Amina Kunnummal, Jasneet Khalsa, Esther Revai-Lechtich, Clemens Reinshagen, Victoria Leon, Nabil Nissar, Wenya Linda Bi, Cheng Feng, Hongbin Li, Yu Shrike Zhang, Steven H Liang, Neil Vasdev, Walid Ibn Essayed, Pablo Valdes Quevedo, Alexandra Golby, Naima Banouni, Anna Palagina, Reza Abdi, Brian Fury, Stelios Manolis Smirnakis, Alarice Lowe, Brock Reeve, Arthur Hiller, E Antonio Chiocca, Glenn Prestwich, Hiroaki Wakimoto, Gerhard Bauer, Khalid Shah
Target receptor identification and subsequent treatment of resected brain tumors with encapsulated and engineered allogeneic stem cells. Nature communications 13 (1) (2022)

Esther Revai-Lechtich.css-eqlu8i{font-size:small;padding-left:4px;} (Esther Revai Lechtich)